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Completed HPV vaccination rates in two distinct populations
of New Jersey
James Cahill, MS4, Dr. Stacey Hammer, MD, Dr. Nicole Leopardi, MD
Abstract
In accordance with updated CDC guidelines from
2018, the vaccination schedule for HPV varies
according to the age of the patient, most critically
by allowing for two injections instead of three if
the process began prior to turning 15 years old. In a
previous study, it was shown that suburban practice
location was associated with higher completion
rates of the HPV vaccine (Chou et. All 2011). By
gathering data from Camden and Moorestown
offices within Cooper Pediatrics, we could evaluate
this assertion within southern New Jersey and
further evaluate if there was a difference in
completion rates by age groups. Using a
retrospective chart review of 320 patients’ data and
using chi-square analysis, it was determined there
was significant statistical difference in vaccine
series completion between the two offices and by
age group.

Methods & Results

Introduction

This study gathered data from 160 patients from Moorestown and 160
from Camden (80 9-14-year-old and 80 15+ year old from each
location.) This is based on historical data of 40% completion in
Caucasian populations and 25% in minority populations with a power
of 80% and alpha of 0.05. Using a chi-square analysis, the compiled
data was analyzed (shown in four charts in center of poster).
Significant difference in the groups was based on p<.05. The degrees
of freedom was 1.
Comparing 9-14-year-old patients from each location, no significant
difference was discovered (P-value is 0.59816). It was found that the
Moorestown location had a significantly higher amount of vaccination
series completions compared to Camden when the series began after
15 years old (P-value is 0.000016 ). When comparing all patients in
Moorestown and Camden, Moorestown patients completed
vaccination series at a significantly higher rate (P-value is 0.000242).
Additionally, the completion rate was significantly higher when the
inoculation began prior to 15 years of age (P-value is <0.00001).

Conclusion
Compared to trends seen in other studies, the data analyzed here
shows a significantly higher completion of vaccine series in a
suburban (Moorestown) population compared to inner-city (Camden).
While the data compiled did not include a patient’s race, historical
data has shown lower rates of completion in minority populations and
could be a data point for comparison in the future (Kester et. All
2013). A potential for further insight would be a questionnaire to
gather thoughts pertaining to vaccines overall and the HPV vaccine
specifically due to a potential perceived connection with sexual
activity. The differences in vaccination rates of males and females
could be another data point. South New Jersey has access to rural
populations as well, which could provide additional access and insight
to large groups of people that often have sub-standard level of access
to healthcare (Mead 2019).

Purpose
Inoculation with HPV vaccine provides a direct
benefit to recipients by safely protecting against
cancers that can result from persistent HPV
infection. This preventive effect is most notable and
best studied with cervical cancer in females, which
is one of the most common female cancers
worldwide. By conducting analysis of vaccination
rates, we can monitor trends in completion with
less required follow-ups if treatment begins at an
earlier age. Additionally, with more information we
can better educate our patients and their family
members about the benefits of beginning this
process earlier, as the the vaccine works best before
any initial exposure to HPV (CDC 2019).
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